Detection primer combination, kit and detection method of strain with gamma-aminobutyric acid synthesis capability

By designing specific detection primer combinations and PCR amplification technology, the problem of difficult detection strains in the existing technology is solved, and the rapid screening of GABA synthetic active strains is achieved, which reduces the development cost and time of probiotics for calming the mind and aiding sleep .

CN118932092AInactive Publication Date: 2024-11-12中原食品实验室
View PDF 5 Cites 0 Cited by

Patent Information

Application Number
CN202411058958.6
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-08-02
Publication Date
2024-11-12
Estimated Expiration
Not applicable · inactive patent

AI Technical Summary

Technical Problem

The prior art lacks a method that can quickly and effectively detect whether a strain has the ability to produce gamma-aminobutyric acid (GABA), resulting in an increase in the development cycle and cost of the calming probiotics.

Method used

A combination of detection primers for synthesizing gamma-aminobutyric acid-capable strains, including gadAF/R, gadB F/R, gadC F/R and gadR F/R primers, was designed, and rapid by PCR amplification and gel electrophoresis technology. Strains with GABA synthetic activity were screened out.

Benefits of technology

The rapid and accurate screening of GABA synthetically active strains has been achieved, the R&D cost of Anshen Sleep Assisted Bacteria has been reduced, the detection accuracy has reached more than 90%, and the verification workload of subsequent fermentation experiments has been reduced.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure BDA0004977222550000071
    Figure BDA0004977222550000071
  • Figure BDA0004977222550000081
    Figure BDA0004977222550000081
  • Figure HDA0004977222560000011
    Figure HDA0004977222560000011
Patent Text Reader

Abstract

The invention discloses a detection primer combination, a kit and a detection method for a strain with gamma-aminobutyric acid synthesis capability. The primer combination comprises a gadA F / R primer pair, a gadB F / R primer pair, a gadC F / R primer pair and a gadR F / R primer pair. The molecular primer provided by the invention has relatively high accuracy, sensitivity and broad spectrum of species, a large amount of potential probiotics with GABA synthesis activity and nerve calming and sleep aiding effects can be rapidly and accurately screened by utilizing the detection method, non-target strains can be rapidly and accurately filtered, the effect verification cost of subsequent fermentation experiments is reduced, and the detection method is suitable for large-scale popularization and application. The research and development cost of the nerve soothing and sleep aiding bacteria is reduced; during detection, the four primer pairs act together, the probability of 90% or above of an isolated strain identified by the four primers for the first time can be determined to be a strain with GABA synthesis activity and nerve calming and sleep aiding effects, and the detection accuracy is high.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention belongs to the technical field of biological detection, and specifically relates to a detection primer combination, a kit and a detection method for a strain capable of synthesizing gamma-aminobutyric acid. Background Art

[0002] γ-aminobutyric acid (GABA) is a non-protein amino acid that plays a key role in the central nervous system of mammals. Its main function is an inhibitory neurotransmitter. Studies have found that GABA not only helps lower blood pressure, fight anxiety, protect the kidneys, promote the secretion of growth hormone and enhance immunity, but its most prominent physiological function is to calm the nerves and help sleep. This effect makes GABA a new functional factor that is highly valued in the food, medicine and breeding industries. As one of the effective methods for producing GABA, probiotics have received widespread attention from the scientific research and industrial communities in recent years. By using specific probiotic strains, GABA can be naturally produced during the fermentation process, which is more environmentally friendly, safe and sustainable. Probiotics can not only synthesize GABA directly in the intestines, but also indirectly enhance the body's own GABA production capacity by promoting intestinal health, thereby exerting effects such as calming the nerves and helping sleep, and fighting anxiety. However, screening and isolating strains with the ability to produce GABA requires determining the GABA production activity of the screened strains through later fermentation tests, which greatly increases the development cycle and cost of probiotics for calming the nerves and helping sleep.

[0003] Currently, there is a lack of a method to detect whether a strain has the ability to produce GABA. This patent proposes an efficient method to detect the GABA-producing activity of probiotics. It can quickly infer whether it has the ability to produce GABA through molecular experiments, thereby reducing the cost of developing calming and sleep-inducing bacteria. Summary of the invention

[0004] The purpose of the present invention is to provide a detection primer combination for a strain capable of synthesizing γ-aminobutyric acid. Providing a detection kit and a detection method is another purpose of the present invention.

[0005] In order to achieve the above-mentioned invention object, the technical solution adopted by the present invention is:

[0006] A detection primer combination for strains capable of synthesizing gamma-aminobutyric acid, comprising a gadAF / R, gadB F / R, gadC F / R and gadR F / R primer pair;

[0007] The gadAF / R primer pair comprises an upstream primer gadAF, whose nucleotide sequence is shown in SEQ No. 1: 5'-AGGATAMKYKCWCACCWATSKK-3'; a downstream primer gadAR, whose nucleotide sequence is shown in SEQ No. 2: 5'-GGAHCGCCTWGTDWYYTSRTAA-3';

[0008] The gadB F / R primer pair includes an upstream primer gadB F, whose nucleotide sequence is shown in SEQ No. 3: 5'-AMRAANGSBATYGACWWVWC-3'; a downstream primer gadB R, whose nucleotide sequence is shown in SEQ No. 4: 5'-GCAGGTACKTSMMVRCCVWW-3';

[0009] The gadC F / R primer pair includes an upstream primer gadC F, whose nucleotide sequence is shown in SEQ No.5: 5'-TKBTWWCWVTGGDTWCAHAT-3'; a downstream primer gadC R, whose nucleotide sequence is shown in SEQ No.6: 5'-AAYAAABGDARHRAHBARHR-3';

[0010] The gadR F / R primer pair includes an upstream primer gadR F, whose nucleotide sequence is shown in SEQ No.7: 5'-GAGATTGTTTTRMWAMATTG-3'; and a downstream primer gadR R, whose nucleotide sequence is shown in SEQ No.8: 5'-TCATTTCTAAAATAAWWTCR-3'.

[0011] The application of the detection primer combination of the strain with the ability to synthesize γ-aminobutyric acid in the preparation of a detection kit for detecting the strain with the ability to synthesize γ-aminobutyric acid.

[0012] The present invention further discloses a detection kit for a strain capable of synthesizing γ-aminobutyric acid, which contains the above detection primer combination.

[0013] In addition, the present invention further discloses a method for detecting a strain capable of synthesizing γ-aminobutyric acid, comprising the following steps:

[0014] Step 1: DNA extraction

[0015] Extracting DNA of the strain whose GABA synthesis activity is to be verified, and obtaining DNA extract from the microorganism;

[0016] Step 2: PCR amplification

[0017] Using the DNA obtained from the microbial DNA extract as a template, PCR amplification was performed using gadAF / R, gadB F / R, gadCF / R and gadR F / R primers to obtain PCR reaction products of four primer pairs, which were recorded as reaction product A, reaction product B, reaction product C and reaction product R, corresponding to the amplification product of gadA gene, the amplification product of gadB gene, the amplification product of gadC gene and the amplification product of gadF gene, respectively;

[0018] Step 3: Gel electrophoresis detection

[0019] Take PCR reaction product A or B and use gel electrophoresis technology to detect; if the gadA gene amplification product detects a characteristic band of 300-550bp on the gel, or the gadB gene amplification product detects a characteristic band of 800-1000bp on the gel, it indicates that the strain has the glutamate decarboxylase encoding gene gadA or gadB; if this characteristic band is not detected, it means that the strain does not have the glutamate decarboxylase encoding gene gadA or gadB;

[0020] Take the PCR reaction product C and use gel electrophoresis technology to detect it; if the characteristic band of 1200-1400bp of the gadC gene amplification product is detected on the gel, it indicates that the strain has the Glu / GABA reverse transporter encoding gene gadC; if this characteristic band is not detected, it means that the strain does not have the Glu / GABA reverse transporter encoding gene gadC;

[0021] Take the PCR reaction product R and use gel electrophoresis technology for detection; if the gadR gene amplification product detects a characteristic band of 600 to 950 bp on the gel, it indicates that the strain contains the gene gadR encoding the transcriptional regulatory factor; if this characteristic band is not detected, it indicates that the strain does not contain the gene gadR encoding the transcriptional regulatory factor.

[0022] As a further preferred embodiment of the present invention, the PCR reaction system is 10 μL in total, including the following components: 2 ng microbial DNA, 1×Taq enzyme buffer, 2 mmol / LMgCl2, 0.2 mmol / L dNTPs, 2.5 pmol / L of upstream and downstream primers respectively, 1 U Taq DNA polymerase, and supplemented to 10 μL with ddH2O.

[0023] As a further preference of the present invention, the reaction conditions of the PCR are:

[0024] (1) Pre-denaturation: Denature the PCR reaction mixture at 94°C for 3 minutes;

[0025] (2) PCR cycles: 35 cycles were performed, each cycle including:

[0026] Denaturation: denature at 94°C for 30 seconds;

[0027] Annealing: anneal at 50-55°C for 30 seconds;

[0028] Extension: 75°C for 30 seconds;

[0029] (3) Final extension: extend at 75°C for 10 minutes.

[0030] The invention collects the orthologous genes of existing gadA, gadB, gadC and gadR from public databases, which are derived from 34, 27, 61 and 63 species respectively, and develops and designs the corresponding molecular primers through bioinformatics analysis technology; in the process of primer design and optimization, the specificity of the sequence, the application of the mixed basis, and the stability and efficiency of the PCR reaction are fully considered, and four groups of primer combinations gadAF / R, gadBF / R, gadCF / R and gadRF / R are obtained. The verification experiment shows that when the verification For strains with GABA synthesis activity, the detection rates of the primer combinations gadAF / R, gadBF / R and gadRF / R were 100%, and the detection rate of gadCF / R was 80%. For strains without GABA synthesis activity, gadA, gadB, gadC and gadR genes were not detected at all. The results showed that the primers gadAF / gadAR, gadBF / gadBR, gadCF / gadCR and gadRF / gadRR had a higher detection accuracy for the negative control group.

[0031] Compared with the prior art, the technical effects of the present invention are:

[0032] The molecular primers provided by the present invention have high accuracy, sensitivity and species broad spectrum. The detection method of the present invention can be used to quickly, massively and accurately screen potential probiotics with GABA synthesis activity and tranquilizing and sleep-inducing effects, quickly and accurately filter non-target strains, reduce the cost of subsequent fermentation experiment effect verification, and reduce the research and development cost of tranquilizing and sleep-inducing bacteria; during the detection, four primer pairs act together, and the isolated strains initially identified by the four primers have a probability of more than 90% that they can be determined to be strains with GABA synthesis activity and tranquilizing and sleep-inducing effects, and have a high detection accuracy rate. BRIEF DESCRIPTION OF THE DRAWINGS

[0033] Figure 1 is the sequencing peak diagram of gadAF / R of the present invention;

[0034] Figure 2 , Figure 3 is the sequencing peak diagram of gadBF / R of the present invention;

[0035] Figure 4is the sequencing peak diagram of gadCF / R of the present invention;

[0036] Figure 5 , Figure 6 This is the sequencing peak diagram of gadR F / R. DETAILED DESCRIPTION

[0037] The present invention is further described in detail below in conjunction with the examples. It should be noted that these examples are provided to facilitate the understanding of the present invention, rather than to limit the content of the present invention. The raw materials used in the present invention can all be purchased from the market.

[0038] Example 1 Primer Design

[0039] GABA production in microorganisms is mainly through the degradation of putrescine (Puu and ADC pathways) or the decarboxylation of glutamate (GAD pathway). However, due to the lack of Puu and ADC pathways, GABA production by putrescine degradation is not common. The GAD operon is mainly composed of genes encoding a transcriptional regulator (gadR), glutamate decarboxylase (gadA or gadB), and a Glu / GABA antiporter (gadC).

[0040] In this regard, the present invention targets key genes in the GABA anabolic pathway, including gadA, gadB, gadC and gadR, collects a total of 719 orthologous genes in the NCBI-GenBank database, and designs corresponding PCR primers gadAF / R, gadBF / R, gadCF / R and gadRF / R through bioinformatics analysis.

[0041] Bioinformatics analysis: Orthologous gene sequences related to gadA, gadB, gadC and gadR genes were collected. The present invention collected orthologous genes of gadA, gadB, gadC and gadR from public databases, which were derived from 34, 27, 61 and 63 species, respectively. These gene sequences were analyzed by bioinformatics analysis technology to determine the common sequence regions for designing primers.

[0042] Primer design: To ensure that the primers can cover a wide range of strains, sequences containing a variety of mixed bases (such as R, Y, K, etc.) were selected. Primers such as gadAF, gadAR, gadBF, gadBR, gadCF, gadCR, gadRF, and gadRR were designed for PCR amplification of target genes. These primers are designed to increase coverage of different strains.

[0043] Primer verification and optimization: Use samples in the laboratory to perform PCR reactions to test the specificity and efficiency of primers. For different strains, the specificity of primers is verified by PCR amplification and gel electrophoresis.

[0044] Scientificity and data support of primer design:

[0045] Coverage: Primer design was based on bioinformatics analysis, and the coverage of gadAF / R, gadBF / R, gadCF / R, and gadRF / R reached 66.8%, 78.1%, 82.6%, and 79.0%, respectively. The isolated strains initially identified by these four primers have a probability of more than 90% to be strains with GABA synthesis activity and tranquilizing and sleep-inducing effects.

[0046] PCR conditions: Reaction system: use 2ng microbial DNA, 1×Taq enzyme buffer, 2mmol / LMgCl2, 0.2mmol / L dNTPs, 2.5pmol / L of upstream and downstream primers, and 1U Taq DNA polymerase.

[0047] PCR cycle: preliminary denaturation at 94°C for 3 min, 35 cycles (denaturation at 94°C for 30 s, annealing at 50-55°C for 30 s, extension at 75°C for 30 s), and final extension at 75°C for 10 min.

[0048] Gel electrophoresis detection: The size of the amplified product of gadA or gadB gene is 300-550bp or 800-1000bp, that of gadC gene is 1200-1400bp, and that of gadR gene is 600-950bp.

[0049] PCR products are analyzed by gel electrophoresis to verify the presence of specific bands, thereby determining whether the primers have successfully amplified the target gene.

[0050] Example 2

[0051] This embodiment provides a method for detecting a strain capable of synthesizing γ-aminobutyric acid, comprising the following steps:

[0052] Step 1: DNA extraction

[0053] Extract DNA from the strain to be verified for GABA synthesis activity; this step is to obtain DNA from microorganisms for subsequent PCR amplification;

[0054] Step 2: PCR amplification

[0055] Using the DNA obtained from the microbial DNA extract as a template, PCR amplification was performed using gadAF / R, gadB F / R, gadCF / R and gadR F / R primers to obtain PCR reaction products of four primer pairs, which were recorded as reaction product A, reaction product B, reaction product C and reaction product R, corresponding to the amplification product of gadA gene, the amplification product of gadB gene, the amplification product of gadC gene and the amplification product of gadF gene, respectively;

[0056] Specifically:

[0057] Using DNA obtained from microbial DNA extracts as a template, PCR amplification was performed using primers gadAF and gadAR of the gadA gene. This amplification process will be used to detect the presence of glutamate decarboxylase encoding genes in the strains;

[0058] Using the DNA obtained from the microbial DNA extract as a template, PCR amplification was performed using the primers gadBF and gadBR of the gadB gene. This amplification process complements the previous step and will be used to detect whether the strain has the glutamate decarboxylase encoding gene;

[0059] Using DNA obtained from microbial DNA extracts as a template, PCR amplification was performed using primers gadCF and gadCR of the gadC gene. This amplification process will be used to detect the presence of the Glu / GABA antiporter encoding gene in the strain;

[0060] Using DNA obtained from microbial DNA extracts as a template, PCR amplification is performed using primers gadRF and gadRR of the gadR gene. This amplification process will be used to detect whether the strains contain genes encoding transcriptional regulators;

[0061] The PCR reaction system was 10 μL in total and included the following components: 2 ng microbial DNA, 1× Taq enzyme buffer, 2 mmol / LMgCl2, 0.2 mmol / L dNTPs, 2.5 pmol / L of upstream and downstream primers, 1 U Taq DNA polymerase, and made up to 10 μL with ddH2O.

[0062] The reaction conditions for PCR were:

[0063] (1) Pre-denaturation: Denature the PCR reaction mixture at 94°C for 3 minutes;

[0064] (2) PCR cycles: 35 cycles were performed, each cycle including:

[0065] Denaturation: denature at 94°C for 30 seconds;

[0066] Annealing: anneal at 50-55°C for 30 seconds;

[0067] Extension: 75°C for 30 seconds;

[0068] (3) Final extension: extend at 75°C for 10 minutes.

[0069] Step 3: Gel electrophoresis detection

[0070] Take the PCR reaction product and use gel electrophoresis technology for detection. If the gadA gene amplification product detects a characteristic band of 300-550bp on the gel, or the gadB gene amplification product detects a characteristic band of 800-1000bp on the gel, it indicates that the strain has the glutamate decarboxylase encoding gene gadA or gadB; if this characteristic band is not detected, it means that the strain does not have the glutamate decarboxylase encoding gene gadA or gadB.

[0071] Take the PCR reaction product and use gel electrophoresis technology for detection. If the gadC gene amplification product detects a characteristic band of 1200-1400 bp on the gel, it indicates that the strain has the Glu / GABA reverse transporter encoding gene gadC; if this characteristic band is not detected, it means that the strain does not have the Glu / GABA reverse transporter encoding gene gadC.

[0072] Take the PCR reaction product and use gel electrophoresis technology for detection. If the gadR gene amplification product detects a characteristic band of 600-950bp on the gel, it indicates that the strain has the gene gadR encoding the transcriptional regulatory factor; if this characteristic band is not detected, it means that the strain does not have the gene gadR encoding the transcriptional regulatory factor.

[0073] Example 3: Verification of strains with GABA synthesis activity

[0074] Take 5 strains (Lactobacillus brevis DSM 20054, Lactobacillus rhamnosus GG, Lactobacillusacidophilus LA-5, Lactobacillus helveticus R0052, Lactobacillus plantarum DS82101) that have been verified to have GABA synthesis activity and belong to the genus Lactobacillus, extract DNA of 5 strains respectively according to step 1 of Example 1, and conduct PCR amplification by guiding gadA or gadB, gadC and gadR gene primers for each DNA sample according to step 2 of Example 1, so as to detect the glutamate decarboxylase encoding gene, the Glu / GABA reverse transporter encoding gene and the encoding transcriptional regulatory factor encoding gene acutely. After completing the PCR reaction, the PCR products were separated by 1.2% polyacrylamide gel electrophoresis, stained with SYBR Green fluorescent dye, and the characteristic bands of PCR amplified DNA were observed by gel imaging.

[0075] Table 1 PCR amplification results of strains with GABA synthesis activity

[0076]

[0077] +: Feature band detected; -: Feature band not detected

[0078] The test results are shown in Table 1. For strains that have been verified to have GABA synthesis activity, this method can detect gadA or gadB and gadR genes in vivo, with a detection success rate of 100%; and the successful detection rate of gadC gene is 80%. These results show that the detection accuracy of gadAF / gadAR, gadBF / gadBR and gadRF / gadRR primers for strains with GABA synthesis activity is higher than that of gadCF / gadCR primers. This rapid detection method can quickly and efficiently detect whether a single bacterium or bacterial agent has GABA synthesis activity and tranquilizing and sleep-inducing effects, thereby reducing the workload of animal in vivo effect verification experiments. The application of this technology will help to quickly screen bacterial agents with GABA synthesis activity and tranquilizing and sleep-inducing effects.

[0079] Example 4: Verification of strains without GABA synthesis activity

[0080] Take 5 strains (Lactobacillus helveticus CICC22171, Lactobacillus acidophilus LA85, Lactobacillus rhamnosus CGMCC1.78, Lactobacillus salivarius CGMCC1.1881, Lactobacillus helveticus CICC 22550) that have been verified to have no GABA synthesis activity, extract DNA of the 5 strains respectively according to step 1, and perform PCR amplification guided by gadA or gadB, gadC and gadR gene primers according to step 2 to acutely detect the glutamate decarboxylase encoding gene, the Glu / GABA reverse transporter encoding gene and the encoding transcriptional regulatory factor encoding gene. After completing the PCR reaction, use 1.2% polyacrylamide gel electrophoresis to separate the PCR products, use SYBR Green fluorescent dye to stain, and observe the characteristic bands of PCR amplified DNA by gel imaging.

[0081] Table 2 PCR amplification results of strains without GABA synthesis activity

[0082]

[0083] +: Feature band detected; -: Feature band not detected

[0084] The test results are shown in Table 2. For strains that have been verified to have no GABA synthesis activity, this method cannot detect gadA or gadB, gadC and gadR genes. These results show that gadAF / gadAR, gadBF / gadBR, gadCF / gadCR and gadRF / gadRR primers have a high detection accuracy for the negative control group. In the practical application of isolating and screening strains with GABA synthesis activity and sedative and sleep-inducing effects, non-target strains can be quickly and accurately filtered, reducing the cost of subsequent fermentation experiment effect verification.

[0085] Figure 1 is the sequencing peak diagram of gadAF / R of the present invention; Figure 2 , Figure 3 is the sequencing peak diagram of gadBF / R of the present invention; Figure 4 is the sequencing peak diagram of gadCF / R of the present invention; Figure 5 , Figure 6 It is the sequencing peak diagram of gadR F / R of the present invention; the above peak diagram is obtained by PCR amplification and gel electrophoresis technology, which is used to confirm whether there is a specific gene in the strain. These genes (gadA, gadB, gadC and gadR) encode glutamate decarboxylase and related regulatory factors respectively, which are important components of the GABA synthesis pathway. By detecting these genes, strains with the ability to synthesize GABA can be screened out, thereby being used to develop probiotics with a calming and sleep-inducing effect. The target strain can be quickly and accurately screened out using this method of the present invention, reducing the cost and time of subsequent fermentation experiments.

[0086] The above embodiments are preferred implementation modes of the present invention, but the implementation modes of the present invention are not limited to the above embodiments. Any other changes, modifications, substitutions, combinations, and simplifications that do not deviate from the spirit and principles of the present invention should be equivalent replacement methods and are included in the protection scope of the present invention.

Claims

1. A primer combination for detecting strains capable of synthesizing γ-aminobutyric acid, characterized in that: Includes gadA F / R, gadB F / R, gadC F / R and gadR F / R primer pairs; The gadA F / R primer pair comprises an upstream primer gadA F, whose nucleotide sequence is shown in SEQ No. 1: 5'-AGGATAMKYKCWCACCWATSKK-3'; a downstream primer gadA R, whose nucleotide sequence is shown in SEQ No. 2: 5'-GGAHCGCCTWGTDWYYTSRTAA-3'; The gadB F / R primer pair includes an upstream primer gadB F, whose nucleotide sequence is shown in SEQ No.3: 5'-AMRAANGSBATYGACWWVWC-3'; a downstream primer gadB R, whose nucleotide sequence is shown in SEQ No.4: 5'-GCAGGTACKTSMMVRCCVWW-3'; The gadC F / R primer pair includes an upstream primer gadC F, whose nucleotide sequence is shown in SEQ No.5: 5'-TKBTWWCWVTGGDTWCAHAT-3'; a downstream primer gadC R, whose nucleotide sequence is shown in SEQ No.6: 5'-AAYAAABGDARHRAHBARHR-3'; The gadR F / R primer pair includes an upstream primer gadR F, whose nucleotide sequence is shown in SEQ No.7: 5'-GAGATTGTTTTRMWAMATTG-3'; and a downstream primer gadR R, whose nucleotide sequence is shown in SEQ No.8: 5'-TCATTTCTAAAATAAWWTCR-3'.

2. Use of the detection primer combination for the strain having the ability to synthesize γ-aminobutyric acid according to claim 1 in the preparation of a detection kit for detecting the strain having the ability to synthesize γ-aminobutyric acid.

3. A detection kit for strains capable of synthesizing γ-aminobutyric acid, characterized in that: Contains the detection primer combination according to claim 1.

4. A method for detecting strains capable of synthesizing γ-aminobutyric acid, characterized in that: The following steps are involved: Step 1: DNA extraction Extracting DNA of the strain whose GABA synthesis activity is to be verified, and obtaining DNA extract from the microorganism; Step 2: PCR amplification The DNA obtained from the microbial DNA extract was used as a template and PCR amplified using gadA F / R, gadB F / R, gadC F / R and gadR F / R primers to obtain the PCR reaction products of four sets of primer pairs, which were recorded as reaction product A, reaction product B, reaction product C and reaction product R, corresponding to gadA Gene amplification products gadB Gene amplification products gadC Gene amplification products and gf Gene amplification products; Step 3: Gel electrophoresis detection Take PCR reaction product A or B and detect it using gel electrophoresis technology; if gadA The gene amplification product detected a characteristic band of 300 to 550 bp on the gel, or gadB The gene amplification product detected a characteristic band of 800-1000 bp on the gel, indicating that the strain has the glutamate decarboxylase encoding gene gadA or gadB If this characteristic band is not detected, it means that the strain does not have the glutamate decarboxylase encoding gene gadA or gadB ; Take PCR reaction product C and detect it using gel electrophoresis technology; if gadC The gene amplification product detected a characteristic band of 1200-1400 bp on the gel, indicating that the strain has the Glu / GABA antiporter encoding gene gadC If this characteristic band is not detected, it means that the strain does not have the Glu / GABA antiporter encoding gene gadC ; Take the PCR reaction product R and use gel electrophoresis technology to detect it; if gadR The gene amplification product detected a characteristic band of 600-950 bp on the gel, indicating that the strain has a gene encoding a transcriptional regulator. gdR If this characteristic band is not detected, it means that the strain does not have a gene encoding a transcriptional regulator. gdR .

5. The method for detecting a strain capable of synthesizing γ-aminobutyric acid according to claim 4, characterized in that: The PCR reaction system was 10 μL in total, including the following components: 2 ng microbial DNA, 1× Taq enzyme buffer, 2 mmol / L MgCl2, 0.2 mmol / L dNTPs, 2.5 pmol / L of upstream and downstream primers, 1U Taq DNA polymerase, and supplemented to 10 μL with ddH2O.

6. The method for detecting a strain capable of synthesizing γ-aminobutyric acid according to claim 4, characterized in that: The reaction conditions of the PCR are: (1) Pre-denaturation: Denature the PCR reaction mixture at 94°C for 3 minutes; (2) PCR cycles: 35 cycles were performed, each cycle included: Denaturation: denature at 94°C for 30 seconds; Annealing: anneal at 50-55°C for 30 seconds; Extension: 75°C for 30 seconds; (3) Final extension: extend at 75°C for 10 minutes.

Citation Information

Patent Citations

  • Glutamate decarboxylase gene and use thereof

    CN102154345A

  • Glutamic acid decarboxylase recombinant plasmid as well as construction method and application thereof

    CN104099366A

  • Efficient production method of gamma-aminobutyric acid

    CN104830745A

  • Recombinant bacterium capable of producing gamma-aminobutyric acid, construction method and applications thereof

    CN104830886A

  • Corynebacterium glutamicum for producing gamma-aminobutyric acid, and building method and application thereof

    CN107674855A